Biopharmaceutical major Biocon has its eyes set on the US insulin market, which is expected to grow to $29.9 billion by 2025, with its interchangeable biosimilar product Semglee that has…
Nagpur: After hosting trials of various types of Covid-19 vaccines and some drugs delivered through injections, Nagpur has become the site for the human trials of an oral pill that…
WASHINGTON: Top US lawmakers have congratulated India after the cumulative COVID-19 vaccine doses administered in the country surpassed the 100-crore milestone, saying India’s success will help the world defeat the…
As a decision is awaited on the Emergency Use Listing of Covaxin being manufactured in India, a top WHO official has said the process of thoroughly evaluating a vaccine for…
London: A drug used to treat agitation in people with dementia is no more effective than a placebo, and might even increase mortality, according to a new study. The research,…
By Julie Steenhuysen CHICAGO: Americans this week were handed a big decision when it comes to getting a COVID-19 vaccine booster. The U.S. Centers for Disease Control and Prevention (CDC)…
New Delhi: Technological advancements made in the healthcare sector has made it more accessible and has enabled better treatment for patients. For further redemption of the economy, collaboration between the…
PUNE: Two Pune hospitals are among the 11 trial sites in India where adolescents are being screened for US pharma major Johnson & Johnson’s Covid vaccine advanced trials this month.…
By Manas Mishra and Julie Steenhuysen The U.S. Centers for Disease Control and Prevention (CDC) on Thursday recommended the COVID-19 vaccine boosters for recipients of the Moderna Inc and Johnson…
Biocon and its partner Viatris said Express Scripts, a leading Pharmacy benefit manager (PBM) Express in US, will be listing interchangeable biosimilar Insulin Glargine sold under brand name Semglee as…
